AAAAAA

   
Results: 1-7 |
Results: 7
DOES THE MOBILIZATION REGIMEN INFLUENCE PERIPHERAL-BLOOD STEM-CELL (PBSC) TUMOR CONTAMINATION IN EARLY BREAST-CANCER PATIENTS THAT UNDERGO HIGH-DOSE CHEMOTHERAPY - A COMPARISON OF CHEMOTHERAPY PLUS G-CSF VS G-CSF MOBILIZED PBSC
Authors: PECCATORI F CINIERI S BERTOLINI F COCOROCCHIO E FERRUCCI F LANZA A AGAZZI A CORSINI C DELLACUNA GR MARTINELLI G
Citation: F. Peccatori et al., DOES THE MOBILIZATION REGIMEN INFLUENCE PERIPHERAL-BLOOD STEM-CELL (PBSC) TUMOR CONTAMINATION IN EARLY BREAST-CANCER PATIENTS THAT UNDERGO HIGH-DOSE CHEMOTHERAPY - A COMPARISON OF CHEMOTHERAPY PLUS G-CSF VS G-CSF MOBILIZED PBSC, European journal of cancer, 34, 1998, pp. 90-90
MULTIPLE HIGH-DOSE CHEMOTHERAPY WITH PERIPHERAL-BLOOD STEM-CELLS (PBSC) REINFUSION IN HIGH-RISK BREAST-CANCER
Authors: COCOROCCHIO E PECCATORI F ZIMATORE M FERRUCCI PF CINIERI S AGAZZI A MARTINELLI G
Citation: E. Cocorocchio et al., MULTIPLE HIGH-DOSE CHEMOTHERAPY WITH PERIPHERAL-BLOOD STEM-CELLS (PBSC) REINFUSION IN HIGH-RISK BREAST-CANCER, Annals of oncology, 9, 1998, pp. 43-43
TESTIS SPARING SURGERY FOLLOWED BY CHEMORADIOTHERAPY IS A SAFE AND CONVENIENT TREATMENT FOR IN-SITU CARCINOMA OF THE TESTIS
Authors: CINIERI S PECCATORI F FERRUCCI PFF MOTTA M COCOROCCHIO E MARSIGLIA H MARTINELLI G
Citation: S. Cinieri et al., TESTIS SPARING SURGERY FOLLOWED BY CHEMORADIOTHERAPY IS A SAFE AND CONVENIENT TREATMENT FOR IN-SITU CARCINOMA OF THE TESTIS, Annals of oncology, 9, 1998, pp. 303-303
INHIBITION OF CFU-GM GROWTH BY IDARUBICINOL CONTAINING PLASMA SAMPLESOBTAINED FROM POOR-PROGNOSIS LYMPHOMA PATIENTS TREATED WITH 3-DAYS INFUSION IDARUBICIN
Authors: CORSINI C MANCUSO P GHIELMINI M ZUCCHETTI M TEALDO F COCOROCCHIO E FERRUCCI PF PECCATORI F DINCALCI M MARTINELLI G
Citation: C. Corsini et al., INHIBITION OF CFU-GM GROWTH BY IDARUBICINOL CONTAINING PLASMA SAMPLESOBTAINED FROM POOR-PROGNOSIS LYMPHOMA PATIENTS TREATED WITH 3-DAYS INFUSION IDARUBICIN, Experimental hematology, 26(8), 1998, pp. 378-378
TWIN ISOLATIONS AFTER HIGH-DOSE CHEMOTHERAPY AND PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANTATION FOR HIGH-RISK BREAST-CANCER - PSYCHOLOGICAL AND MICROBIOLOGICAL ASSESSMENT
Authors: COCQUIO A ROBERTA M ILARIA M ANTONELLA D COMPARE L ORLANDO L ROSSETTI F CASELLATO L COCOROCCHIO E PECCATORI F MARTINELLI G
Citation: A. Cocquio et al., TWIN ISOLATIONS AFTER HIGH-DOSE CHEMOTHERAPY AND PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANTATION FOR HIGH-RISK BREAST-CANCER - PSYCHOLOGICAL AND MICROBIOLOGICAL ASSESSMENT, Bone marrow transplantation, 21, 1998, pp. 922-922
IDARUBICIN AND MELPHALAN AS MYELOABLATIVE REGIMEN AFTER SEQUENTIAL HIGH-DOSE CHEMOTHERAPY FOR LYMPHOMAS - PRELIMINARY-RESULTS OF A PHASE I-II STUDY WITH PHARMACOKINETIC GUIDED PERIPHERAL-BLOOD PROGENITOR-CELL REINFUSION
Authors: PECCATORI F COCOROCCHIO E MUNZONE E CORSINI C ZUCCHETTI M FERRUCCI PF CINIERI S DINCALCI M MARTINELLI G
Citation: F. Peccatori et al., IDARUBICIN AND MELPHALAN AS MYELOABLATIVE REGIMEN AFTER SEQUENTIAL HIGH-DOSE CHEMOTHERAPY FOR LYMPHOMAS - PRELIMINARY-RESULTS OF A PHASE I-II STUDY WITH PHARMACOKINETIC GUIDED PERIPHERAL-BLOOD PROGENITOR-CELL REINFUSION, Blood, 90(10), 1997, pp. 4381-4381
INTERMEDIATE AND HIGH-GRADE MALIGNANT NON-HODGKINS-LYMPHOMAS - PRELIMINARY-RESULTS USING A NEW COMBINATION REGIMEN (EVE-COPEM)
Authors: BATTISTA C PANZA N CHIURAZZI B IODICE G ESPOSITO G COCOROCCHIO E BEVILACQUA N PACILIO G
Citation: C. Battista et al., INTERMEDIATE AND HIGH-GRADE MALIGNANT NON-HODGKINS-LYMPHOMAS - PRELIMINARY-RESULTS USING A NEW COMBINATION REGIMEN (EVE-COPEM), Biomedicine & pharmacotherapy, 47(4), 1993, pp. 145-154
Risultati: 1-7 |